Clinical Trial Update: Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 randomized, placebo-controlled trial evaluating glutamine for peripheral neuropathy in breast cancer patients; the study has completed and results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Peripheral Neuropathy

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Peripheral Neuropathy, Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-08-18